These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 15673743)
1. Bactericidal action of gatifloxacin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Paramasivan CN; Sulochana S; Kubendiran G; Venkatesan P; Mitchison DA Antimicrob Agents Chemother; 2005 Feb; 49(2):627-31. PubMed ID: 15673743 [TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin and gatifloxacin in an acid model of persistent Mycobacterium tuberculosis. Kubendiran G; Paramasivan CN; Sulochana S; Mitchison DA J Chemother; 2006 Dec; 18(6):617-23. PubMed ID: 17267339 [TBL] [Abstract][Full Text] [Related]
3. Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis. Herbert D; Paramasivan CN; Venkatesan P; Kubendiran G; Prabhakar R; Mitchison DA Antimicrob Agents Chemother; 1996 Oct; 40(10):2296-9. PubMed ID: 8891133 [TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of moxifloxacin on exponential and stationary phase cultures of Mycobacterium tuberculosis. Sulochana S; Mitchison DA; Kubendiren G; Venkatesan P; Paramasivan CN J Chemother; 2009 Apr; 21(2):127-34. PubMed ID: 19423464 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents. Lu T; Drlica K J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961 [TBL] [Abstract][Full Text] [Related]
6. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Jindani A; Doré CJ; Mitchison DA Am J Respir Crit Care Med; 2003 May; 167(10):1348-54. PubMed ID: 12519740 [TBL] [Abstract][Full Text] [Related]
7. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Bhusal Y; Shiohira CM; Yamane N Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578 [TBL] [Abstract][Full Text] [Related]
8. Sterilizing activities of fluoroquinolones against rifampin-tolerant populations of Mycobacterium tuberculosis. Hu Y; Coates AR; Mitchison DA Antimicrob Agents Chemother; 2003 Feb; 47(2):653-7. PubMed ID: 12543673 [TBL] [Abstract][Full Text] [Related]
9. Gatifloxacin in combination with rifampicin in a murine tuberculosis model. Cynamon M; Sklaney MR; Shoen C J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504 [TBL] [Abstract][Full Text] [Related]
10. Sterilising action of pyrazinamide in models of dormant and rifampicin-tolerant Mycobacterium tuberculosis. Hu Y; Coates AR; Mitchison DA Int J Tuberc Lung Dis; 2006 Mar; 10(3):317-22. PubMed ID: 16562713 [TBL] [Abstract][Full Text] [Related]
11. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Dickinson JM; Mitchison DA Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):367-71. PubMed ID: 6784622 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the bactericidal activity of various fluoroquinolones against Mycobacterium tuberculosis in an in vitro experimental model. Cremades R; Rodríguez JC; García-Pachón E; Galiana A; Ruiz-García M; López P; Royo G J Antimicrob Chemother; 2011 Oct; 66(10):2281-3. PubMed ID: 21733966 [TBL] [Abstract][Full Text] [Related]
13. Rapid direct detection of multiple rifampin and isoniazid resistance mutations in Mycobacterium tuberculosis in respiratory samples by real-time PCR. Marín M; García de Viedma D; Ruíz-Serrano MJ; Bouza E Antimicrob Agents Chemother; 2004 Nov; 48(11):4293-300. PubMed ID: 15504855 [TBL] [Abstract][Full Text] [Related]
14. Rapid genotypic detection of rifampin- and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. Bang D; Bengård Andersen A; Thomsen VØ J Clin Microbiol; 2006 Jul; 44(7):2605-8. PubMed ID: 16825393 [TBL] [Abstract][Full Text] [Related]
16. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro. Paramasivan CN; Herbert D; Prabhakar R Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638 [TBL] [Abstract][Full Text] [Related]
17. Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru. De Kantor IN Int J Tuberc Lung Dis; 2006 Jun; 10(6):707; author reply 707-8. PubMed ID: 16776461 [No Abstract] [Full Text] [Related]
18. Isoniazid's bactericidal activity ceases because of the emergence of resistance, not depletion of Mycobacterium tuberculosis in the log phase of growth. Gumbo T; Louie A; Liu W; Ambrose PG; Bhavnani SM; Brown D; Drusano GL J Infect Dis; 2007 Jan; 195(2):194-201. PubMed ID: 17191164 [TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanisms of mycobacterium tuberculosis strains resistance to rifampicin and isoniazid]. Stepanshina VN; Panfertsev EA; Mitrofanova GN; Korobova OV; Stepanshin IuG; Shemiakin IG; Medvedeva IM Probl Tuberk; 2000; (1):32-6. PubMed ID: 10750428 [TBL] [Abstract][Full Text] [Related]
20. Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosis. Gillespie SH; Gosling RD; Uiso L; Sam NE; Kanduma EG; McHugh TD J Antimicrob Chemother; 2005 Dec; 56(6):1169-71. PubMed ID: 16223939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]